PANACEA ACQUISITION CORP II's ticker is PANA and the CUSIP is G6882C106. A total of 47 filers reported holding PANACEA ACQUISITION CORP II in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,689,854 | -3.4% | 165,672 | -4.5% | 0.05% | +15.6% |
Q4 2022 | $1,749,606 | +3.0% | 173,400 | 0.0% | 0.04% | +21.6% |
Q3 2022 | $1,699,000 | +0.4% | 173,400 | 0.0% | 0.04% | -2.6% |
Q2 2022 | $1,692,000 | -0.2% | 173,400 | 0.0% | 0.04% | -13.6% |
Q1 2022 | $1,696,000 | +0.8% | 173,400 | 0.0% | 0.04% | +2.3% |
Q4 2021 | $1,682,000 | -0.5% | 173,400 | 0.0% | 0.04% | -10.4% |
Q3 2021 | $1,691,000 | -2.5% | 173,400 | 0.0% | 0.05% | -2.0% |
Q2 2021 | $1,734,000 | – | 173,400 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RIT CAPITAL PARTNERS PLC | 900,000 | $9,000,000 | 3.04% |
MYDA Advisors LLC | 600,000 | $6,009,000 | 1.50% |
Sage Rock Capital Management LP | 382,500 | $3,831,000 | 0.50% |
683 Capital Management, LLC | 1,400,000 | $14,022,000 | 0.48% |
Bain Capital Life Sciences Investors, LLC | 500,000 | $5,010,000 | 0.33% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 886,642 | $8,866,000 | 0.25% |
Consonance Capital Management LP | 200,000 | $2,002,000 | 0.24% |
Governors Lane LP | 250,000 | $2,504,000 | 0.18% |
Boxer Capital, LLC | 500,000 | $5,010,000 | 0.18% |
Greenlight Capital | 275,000 | $2,754,000 | 0.17% |